Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: future royalty payments

All possibilities, IMO.  I actually think that "retaining jurisdiction" is just standard practice so another jurisdiction doesn't have to "re-invent the wheel".

SGE

Share
New Message
Please login to post a reply